Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.
La Rosee, P; Horne, A; Hines, M; Greenwood, TV B; Machowicz, R; Berliner, N; Birndt, S; Gil-Herrera, J; Girschikofsky, M; Jordan, MB; et al.
Blood.
2019;
133:2465-2477.
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.
Gurunathan, A; Boucher, AA; Mark, M; Prus, KM; O'Brien, MM; Breese, EH; Mizukawa, BE; Absalon, MJ; Nelson, AS; Jordan, MB; et al.
Pediatric Blood and Cancer.
2018;
65:e27400-e27400.
Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis.
Lucchini, G; Marsh, R; Gilmour, K; Worth, A; Nademi, Z; Rao, A; Booth, C; Amrolia, P; Silva, J; Chiesa, R; et al.
Blood.
2018;
132:2088-2096.
Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults.
Rotz, SJ; Ware, RE; Kumar, A.
Pediatric Blood and Cancer.
2018;
65:e27260-e27260.
CNS Langerhans Cell Histiocytosis: Common Hematopoietic Origin for LCH-Associated Neurodegeneration and Mass Lesions.
McClain, KL; Picarsic, J; Chakraborty, R; Zinn, D; Lin, H; Abhyankar, H; Scull, B; Shih, A; Lim, KP H; Eckstein, O; et al.
Cancer.
2018;
124:2607-2620.
Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar, B; Garcia, M; Weng, L; Jung, X; Murakami, JL; Hu, X; McDonald, T; Lin, A; Kumar, AR; DiGiusto, DL; et al.
Leukemia.
2018;
32:575-587.
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
Hashem, H; Kumar, AR; Mueller, I; Babor, F; Bredius, R; Dalal, J; Hsu, AP; Holland, SM; Hickstein, DD; Jolles, S; et al.
Blood.
2017;
130:2682-2688.
Impaired immune function in children and adults with Fanconi anemia.
Myers, KC; Sauter, S; Zhang, X; Bleesing, JJ; Davies, SM; Wells, SI; Mehta, PA; Kumar, A; Marmer, D; Marsh, R; et al.
Pediatric Blood and Cancer.
2017;
64:e26599-e26599.
Low IgE Is Insufficiently Sensitive to Guide Genetic Testing of STAT3 Gain-of-Function Mutations.
Tangye, SG; Forbes, LR; Leiding, J; Preece, K; Kumar, AR; Gambineri, E; Milner, JD; Cooper, MA; Seppanen, M.
Clinical Chemistry (Washington, DC): international journal of molecular diagnostics and laboratory medicine.
2017;
63:1539-1540.
Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.
Khandelwal, P; Teusink-Cross, A; Davies, SM; Nelson, AS; Dandoy, CE; El-Bietar, J; Marsh, RA; Kumar, AR; Grimley, MS; Jodele, S; et al.
Biology of Blood and Marrow Transplantation.
2017;
23:1122-1127.